57.1 F
New York
Sunday, October 18, 2026

Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman

BusinessEli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman
Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman
ClipPlayer-author
By ClipPlayer-author



Evan Seigerman, BMO Capital, joins ‘Fast Money’ to discuss BMO’s inaugural GLP-1 conference.



Source link

Check out our other content

Check out other tags:

(NYSE:(TSX:#KeepItOn% increase%INR:US

Most Popular Articles

© All Rights Reserved, The World Politics.